Quantcast
Channel: Life Science Investing News» Melissa Pistilli
Browsing latest articles
Browse All 8 View Live

OncoGenex Undervalued in Cancer Treatment Resistance Market

OncoGenex Pharmaceuticals is developing solutions to the challenge of overcoming increasing resistance to cancer treatments and offers upside opportunity to investors targeting undervalued biotech...

View Article



Growing Market for Cardiac and Breast Imaging Technologies

Global medical imaging market revenues are expected to grow from $24.1 billion in 2012 to nearly $30 billion by 2017. Continue reading...

View Article

BUY-Rated Clinical-Stage Companies: Keryx Biopharmaceuticals and TG Therapeutics

Life Science Investing news spoke with Jonathan Aschoff, an analyst at Brean Capital, LLC, about clinical-stage companies Keryx Biopharmaceuticals and TG Therapeutics.Continue reading...

View Article

Hepatitis C Virus Therapeutics Market in Overdrive

HCV therapeutics is one of the fastest-developing markets in healthcare with a projected worth of $20 billion by 2020. Several companies are now positioning themselves to be the markets leaders...

View Article

Verastem, Bellus Health Get Orphan Drug Designations

Verastem, Inc. and Bellus Health received orphan drug designations for their product candidates. Orphan drugs are expected to show an ROI of 1.7 times that of non-orphan drugs by 2018.Continue reading...

View Article


Cancer Treatment R&D: Graphene-based Photothermal Therapy

Calevia Inc., a private biotechnology company formed in partnership with ProScanRxPharma Inc. and Grafoid Inc, is now working to develop a graphene-based therapeutic platform for various cancers....

View Article

Plant-based, Omega-rich Food Products & Technologies

More than two-thirds of the global omega-3 market is supplied by Peruvian anchovy fisheries; however, these fisheries are near capacity. Hemp, with its perfect ratio (3:1) of Omega-6 to Omega-3...

View Article

Global Vaccine Market Experiencing Substantial Growth

Totaling just US$5 billion in 2000, today the global vaccine market is worth an estimated $24 billion and is projected to rise to $100 billion by 2025. Continue reading...

View Article

Browsing latest articles
Browse All 8 View Live




Latest Images